Cookie Policy

Updated on 31/10/23

Table of Contents

Introduction

This Cookie Policy applies to the website https://www.recordatirarediseases.co.uk (hereinafter “Site“) is managed, with reference to the processing of the personal data of users who visit it. The Site is managed by Recordati UK Ltd, with registered office in Breakspear Park, Breakspear Way, Hemel Hempstead, HP2 4TZ, United Kingdom and Recordati Rare Diseases UK Ltd with registered office at Greengarth, Thicket Grove, Maidenhead, Berkshire, England, SL6 4LW (hereinafter collectively referred to “Recordati“, “we“, “us“), in its capacity as data controller. The Privacy Policy of the Site is available here.

 

This Cookie Policy describes the use of cookies and other similar technologies within our Site. Any third-party websites accessed from this Site are not covered by this Cookie Policy.

 

You can set your browser not to accept cookies, as explained below in the “Manage cookies” section. When cookies are disabled, some features of our Site may not function properly.

 

What are cookies and other technologies?

Cookies are small files sent by websites you visit and stored on the device you use to access those sites. When users visit the same site again, the browser reads the cookies stored on the device and transmits the information back to the site that originally created or installed those cookies.

 

Cookies are divided according to their duration into:

  • session cookies, when they are automatically deleted at the end of the browsing session; and
  • permanent cookies, when they remain stored on the user’s device even after the closure of the browsing session, for a time established by the creator of the cookie itself. These cookies are automatically deleted once the pre-set duration period has elapsed or alternatively they can be deleted directly by the user as indicated in the appropriate section of this Cookie Policy.

Depending on where they come from, cookies can be divided into:

  • first-party cookies, when they are set and managed directly by the site manager; and
  • third-party cookies, when they are managed by a domain other than the one visited by the user.

In addition, cookies are divided according to their function into:

  • technical cookies, which are necessary for the operation of the site, including the provision of information society services requested by users; and
  • profiling cookies, aimed at creating user profiles and used in order to send and show advertising messages in line with the preferences expressed by the user while browsing.
What types of cookies and similar technologies are used by this site and what they are used for?

This Site uses technical cookies. The legal basis for the processing of personal data in relation to technical cookies is our legitimate interest consisting of the interest in ensuring that the Site functions properly, is visible and accessible to users. Below is a breakdown of the cookies used by our Site:

Name
Source
Purpose
Duration
Type
PHPSESSID
Website
It identifies the user's browsing session in order to continue it when the user returns to the website. Allows the identification of the user in the login area.
Sessions
Technical, first-party cookie
Managing cookies

If you want to delete or check the cookies installed on your device, you can access your web browser settings. Here are the links you can follow for the main web browsers:

 

Microsoft Edge: https://support.microsoft.com/en-us/microsoft-edge/view-cookies-in-microsoft-edge-a7d95376-f2cd-8e4a-25dc-1de753474879  

 

Chrome: http://support.google.com/chrome/bin/answer.py?hl=en-GB&hlrm=nl&answer=95647

 

Firefox: http://support.mozilla.org/en-US/kb/enable-and-disable-cookies-website-preferences?s=cookies&r=5&as=s

 

Safari: http://support.apple.com/kb/PH5042

 

You can also disable cookies through the www.youronlinechoices.com/it portal

 

If you disable the cookies that this Site uses, some of the features of this Site may not be displayed correctly.

 

To object to the use of profiling tools other than cookies, we invite you to exercise your rights by contacting us at the contact details below.

 

Your rights in relation to the processing of your personal data

You can exercise your rights regarding the processing of your personal data by contacting the Data Controller or the Data Protection Officer (DPO) at the contact details below. For more information on your rights of access, rectification, erasure, opposition, restriction of processing and data portability, please visit our Privacy Policy. You can also lodge a complaint with the competent supervisory authority.

 

Data controller and data protection officer (DPO)

This Site is managed by Recordati as described above, as Data Controller.

 

Recordati has appointed a DPO who can be contacted at the following email address:

 

Changes to this cookie policy

This Cookie Policy may be updated over time; in this case, we will notify visitors of the change to this Cookie Policy through a special banner or pop-up message.

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to support.microsoft.com

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to clinicaltrials.gov

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to hpra.ie

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to yellowcard.mhra.gov.uk

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to search.disclosureuk.org.uk

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to support.apple.com

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to support.mozilla.org

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to support.google.com

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to youronlinechoices.com

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to edpb.europa.eu

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to edoeb.admin.ch

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to ico.org.uk

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to careers.recordati.com

ACCEPT
GO BACK
Recordati for the planet
A clean environment is essential for people’s well-being: the health of the planet and the health of people is tightly interconnected. Environmental elements, such as air, water, land and climate, all have an impact on the well-being of humans. Placing a focus on people’s health and being sustainable therefore also means prioritising environmental protection and a responsibility towards future generations. This is why the Group ensures that it conducts business in a socially responsible manner and in accordance with sustainable practices, national and international laws, and the expectations of stakeholders.
Recordati for the community
We believe that contributing to the well-being of the community and dedicating part of our resources to acts of solidarity is not merely the fulfilment of company obligations or professional duty, but rather a moral imperative, an essential part of a healthy business capable of growth but at the same time able to support and develop the community in which it operates and make its employees proud.
Value and diversity of our people
At Recordati, we believe in equal opportunities and we guarantee that everyone can achieve their potential. We see diversity as a value and will not tolerate any discrimination based on ethnicity, nationality, gender, sexual orientation, disability, age, political or religious belief, or any other personal characteristics. At Recordati, we work hard to create a safe and inclusive work environment, where we all have our rights to physical and psychological integrity respected on a daily basis, as well as our right to freedom of opinion and association. We recognise that we each have a role to play in the success of our business and we implement staff development policies through which everyone’s contribution and achievements can be appropriately rewarded.
Multiple opportunities
Recordati is uniquely structured to bring treatment options across specialty and primary care, consumer healthcare, and rare diseases. We have fully integrated operations across research and development, chemical and finished product manufacturing through to commercialisation and licensing.
Luigi Longinotti
Managing Director and General Manager EMEA

Luigi Longinotti is Managing Director and General Manager for EMEA at Recordati Rare Diseases, leading the European and Middle Eastern Commercial Operations. He is responsible for Marketing, Medical, Market Access, Regulatory, Manufacturing and Logistics, as well as the enabling functions to support the business, including Compliance and Quality.

 

He joined Recordati in July 2014 as Corporate Portfolio Management Director for Orphan Drugs. In such a role he has been responsible for driving the growth of the rare disease portfolio at Recordati, with his duties ranging from business development to strategic marketing and pipeline project management.

 

Before he joined Recordati, he held senior business and corporate development roles at Chiesi Farmaceutici and Menarini Group where he executed several key asset deals and transactions.

Luigi gained a degree in Economics from the University of Florence and a Master’s degree in Business Innovation from Sant’Anna School of Advanced Studies in Pisa.

Bruno Parenti
Head of LAC Region, Head of Global Endocrinology Franchise

Bruno Parenti is Head of LAC Region at Recordati Rare Diseases, leading the business in Latin America, Asia Pacific and Russia. He has been in this position since 2011, where he spearheaded the expansion of operations around the globe. He recently assumed the additional role of Head of Global Endocrinology Franchise, establishing the new HQ in Basel and building a dedicated organization.

 

Prior to these positions, Bruno spent two years at Recordati Ireland overseeing international sales in the Asia-Pacific region. He served at Chiesi Farmaceutici for two years as Area Manager for the Far East. Earlier in his career, he held commercial roles at Kedrion Biopharmaceuticals where he was responsible for international markets with a focus on Latin America and the Middle East.

Mohamed Ladha
President and General Manager, North America

Mohamed Ladha is the President and General Manager at Recordati Rare Diseases where he is   responsible for the US and Canadian business. During his career,  Mohamed has held numerous leadership positions globally in hematology/oncology and specialty care to oversee business in the US, Canada, EU, China, Emerging Markets, and Japan.

 

Mohamed  joins Recordati Rare Diseases from Oncopeptides, where he was the General Manager and Executive Vice President for the US Region Business Unit. Prior to Oncopeptides, he served in a series of leadership positions of increasing responsibility at companies including Vertex Pharmaceuticals, Pfizer, Schering-Plough, Merck & Company, Hospira, ARIAD Pharmaceuticals, Takeda Oncology, and Tocagen. He started his career in basic science research focused in oncology at the Dana-Farber Cancer Institute.

 

Mohamed graduated from Hampshire College with a Bachelor of Arts degree. He also holds professional/graduate degrees from Harvard University’s Kennedy School of Government and Northwestern University’s Kellogg School of Management.

 

Changing to first name to be consistent with bio below, also feel that first name as opposed to Mr has a more informal and friendly tone.   [EC1]

Scott Pescatore
Executive Vice President

Scott Pescatore is Vice President and Head of Global Operations at Recordati Rare Diseases.

He holds a Doctor of Pharmacy degree and completed his post-doctoral fellowship in Pharmacology and Drug Development. Dr Pescatore has spent over 20 years working internationally in the pharmaceutical industry, specializing in oncology, haematology and rare diseases.

 

He joined Novartis Oncology US in 2001 where he served in various medical, sales and marketing roles of increasing responsibility. In 2008, he moved to Novartis Oncology UK as Business Franchise Head for solid tumours where he also managed the New Products portfolio. In 2010 he moved to Milan to manage the Region Europe Haematology Franchise where he led the joint venture between Novartis Oncology and Incyte to launch a novel treatment for myeloproliferative disorders. In 2014 he was appointed the Oncology General Manager in Ireland and after three years returned to Milan as General Manager of the Region Europe Rare Disease Business Unit, overseeing operations in 37 markets and focusing on the endocrinology portfolio.

 

Prior to joining Recordati Rare Diseases in 2020, he was Vice President Oncology Business Unit for AstraZeneca Italy where he was responsible for the portfolio of oncology/haematology products including two joint ventures with MSD and Daiichi Sankyo.

You are about to leave this site and visit the recordati global website?

To continue please click the link below.

Visit Global Site